Vindesine, cisplatin, and bleomycin combination chemotherapy in non-small cell lung cancer: survival and quality of life-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Vindesine, cisplatin, and bleomycin combination chemotherapy in non-small cell lung cancer: survival and quality of life

Published:1986-08 Issue:8 Volume:22 Page:963-970
ISSN:0277-5379
Container-title:European Journal of Cancer and Clinical Oncology
language:en
Short-container-title:European Journal of Cancer and Clinical Oncology

Author:

Bakker W.,van Oosterom A.T.,Aaronson N.K.,van Breukelen F.J.M.,Bins M.C.,Hermans J.

Publisher

Elsevier BV

Subject

Oncology

Reference50 articles.

1. Chemotherapy and radiation therapy of non-small cell lung carcinoma;Hande,1983

2. Chemotherapy of metastatic non-small cell bronchogenic carcinoma;Hoffman;Semin Oncol,1983

3. Management of inoperable squamous cell, adeno- and large cell carcinoma;Bleehen,1980

4. Phase II evaluation of vindesine in patients with non-small cell carcinoma of the lung;Gralla;Cancer Treat Rep,1979

5. Vindesine in the treatment of squamous cell carcinoma, adenocarcinoma, and large cell carcinoma of the lung;Østerlind;Cancer Treat Rep,1982

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quality of Life in Lung Cancer;Lung Cancer;2013-04-03

2. Phase I/II study of paclitaxel, gemcitabine and vinorelbine as first-line chemotherapy of non-small-cell lung cancer;Annals of Oncology;2002-12

3. Phase I/II Study of Gemcitabine Plus Vinorelbine as First-Line Chemotherapy of Non–Small-Cell Lung Cancer;Journal of Clinical Oncology;2000-01-01

4. Relationship between quality of life and clinical outcomes in advanced non-small cell lung cancer: best supportive care (BSC) versus BSC plus chemotherapy;Lung Cancer;1999-04

5. Phase II study of gemcitabine and vindesine in patients with previously untreated non-resectable non-small-cell lung cancer;British Journal of Cancer;1999-01-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3